Percutaneous Right Ventricular Support via ProtekDuo Pulmonary Artery Cannulation

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Background:

• Acute right heart failure (RHF) presents significant challenges in patient management.
• Effective hemodynamic support is crucial for improving outcomes in RHF.
• Percutaneous interventions offer a less invasive approach to circulatory support.

Purpose of the Study:

• To evaluate the efficacy and outcomes of ProtekDuo dual-lumen cannula implantation for percutaneous right ventricular support in patients with acute right heart failure.
• To identify factors influencing mortality in patients receiving ProtekDuo support.

Main Methods:

• Retrospective analysis of 60 patients who underwent ProtekDuo implantation for acute right heart failure.
• Assessment of hemodynamic parameters, including central venous pressure and oxygen saturation.
• Evaluation of end-organ function markers such as creatinine, lactate, and bilirubin levels.
• Statistical analysis to identify independent mortality risk factors.

Main Results:

• ProtekDuo support led to significant hemodynamic improvements, including reduced central venous pressure and increased central venous oxygen saturation.
• End-organ function improved, evidenced by decreased creatinine and lactate levels.
• Independent mortality risk factors identified were female sex, older age, and higher body mass index (BMI).
• Transient increases in bilirubin levels were observed but normalized in successfully weaned patients.

Conclusions:

• Percutaneous ProtekDuo implantation is an effective strategy for providing right ventricular support in acute right heart failure.
• Patient selection is a critical determinant of successful outcomes.
• Further research is warranted to refine patient selection criteria and optimize therapeutic strategies for ProtekDuo support.